正乾金融控股(01152.HK)中期亏损收窄9.9%至1162.1万港元
格隆汇8月23日丨正乾金融控股(01152.HK)发布中期业绩,截至2019年6月30日止6个月,公司实现收入5305万港元,同比减少24.3%;毛利443万港元,同比增长109.3%;公司拥有人应占期内亏损1162.1万港元,同比收窄9.9%;基本每股亏损1.18港仙;不派中期股息。
报告期内,集团主要业务录得收益约5305万港元,较去年同期收益减少24.3%。主要由于营养食品产品贸易业务录得收益约5022.9万港元,较去年同期减少27.7%;融资租赁分部录得收益约282.1万港元,较去年同期增加367.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.